Treatment of negative symptoms: Where do we stand, and where do we go?

@article{Aleman2017TreatmentON,
  title={Treatment of negative symptoms: Where do we stand, and where do we go?},
  author={Andr{\'e} Aleman and Tania M. Lincoln and Richard Bruggeman and Ingrid Melle and Johan Arends and Celso Arango and Henderikus Knegtering},
  journal={Schizophrenia Research},
  year={2017},
  volume={186},
  pages={55-62}
}
Negative symptoms, e.g. social withdrawal, reduced initiative, anhedonia and affective flattening, are notoriously difficult to treat. In this review, we take stock of recent research into treatment of negative symptoms by summarizing psychosocial as well as pharmacological and other biological treatment strategies. Major psychosocial approaches concern social skills training, cognitive behavior therapy for psychosis, cognitive remediation and family intervention. Some positive findings have… Expand
Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review
TLDR
An overview of reviews and meta-analyses of double-blind, controlled randomised trials, in which the efficacy of pharmacological and non-pharmacological interventions for negative symptoms was assessed is presented. Expand
EPA guidance on treatment of negative symptoms in schizophrenia
TLDR
Recommendations for the treatment of undifferentiated negative symptoms (including both primary and secondary negative symptoms) are provided and although it has proven difficult to formulate an evidence-based recommendation for the choice of an antipsychotic, a switch to a second-generation antipsychotics should be considered. Expand
Managing Negative Symptoms of Schizophrenia: How Far Have We Come?
TLDR
This review includes studies published since 2014 with a primary or secondary focus on treating negative symptoms in schizophrenia, and Topics include novel pharmacological approaches, including glutamatergic-based and nicotinic-acetylcholinergic treatments, treatments approved for other indications by the US FDA, and brain stimulation, and behavioral- and activity-based approaches. Expand
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
TLDR
The objective of this review was to provide information that may be useful for clinicians treating patients with negative symptoms of schizophrenia, which constitute an unmet medical need in schizophrenia and new and effective treatments are urgently needed. Expand
Identifying the “Therapy Targets” for Treating the Negative Symptoms of Psychosis Using Cognitive Behavioral Therapy
TLDR
This review provides a re-evaluation of the theoretical literature on negative symptoms to inform and identify “treatment targets” to reduce them and a review of the empirical literature on cognitive behavior therapy for treating negative symptoms is offered. Expand
Negative symptoms of schizophrenia: new developments and unanswered research questions.
TLDR
If substantial progress is to be made in the understanding and treatment of negative symptoms, then advances in concepts and assessment should be integrated into the design of future studies of these symptoms. Expand
2 Methodological Considerations 2 . 1 Search Strategy and Selection Criteria
Negative symptoms (such as amotivation and diminished expression) associated with schizophrenia are a major health concern. Adequate treatment would mean important progress with respect to quality ofExpand
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning
TLDR
The presence of short-term PNS during the first phases of psychosis was associated with poor clinical outcome and resistance to antipsychotic treatment, including clozapine. Expand
Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial
TLDR
PEPS is an effective intervention to reduce anhedonia in schizophrenia and is a short, easy-to-use, group-based, freely available intervention that is easy to implement in a variety of environments. Expand
Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial
TLDR
The beneficial effects of CR appear to extend beyond cognition to improvements in negative symptoms and social functioning in early course schizophrenia patients, suggesting that cognitive remediation might have an impact when the reduction of risk factors for chronicity is most critical for promoting recovery. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 102 REFERENCES
Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.
TLDR
Of the interventions reviewed, CBT and SST appear to have the most empirical support, with some evidence suggesting that CBT is associated with maintenance of negative symptom improvement beyond six months after treatment, and it remains unclear if a combined treatment approach provides improvements above and beyond those associated with each individual treatment modality. Expand
Pharmacological treatment of negative symptoms in schizophrenia
TLDR
In general, the second-generation antipsychotics (SGAs) do not appear to have good efficacy in negative symptoms, although some show better efficacy than first-generation anti-schizophrenia drugs, some of which also demonstrated efficacy innegative symptoms. Expand
A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities
TLDR
Improvement of NSS after psychostimulant administration is reviewed both in challenge and treatment paradigms with various agents such as methylphenidate, amphetamine, and modaf inil or armodafinil. Expand
Adapted cognitive–behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression
TLDR
The co-occurring beneficial effect of conventional CBT on negative symptoms found in older studies was not supported by more recent studies, and it is now necessary to further disentangle effective treatment ingredients of older studies in order to guide the development of future CBT interventions aimed at negative symptom reduction. Expand
Secondary negative symptoms — A review of mechanisms, assessment and treatment
TLDR
The relevance of recent developments in psychopathological assessment of negative symptoms, such as the distinction between amotivation and diminished expression, are emphasized, which have only rarely been applied in research on secondary negative symptoms. Expand
The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms
TLDR
The development and mechanistic understanding of anti-negative symptom drugs may be informative regarding pathophysiology of primary negative symptoms and new mechanisms of drug action appear to be required to address this aspect of the disease syndrome. Expand
Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases
TLDR
The evolution of concepts and assessment modalities relevant to PPNS, data on prevalence of DS and PNS, as well as studies on clinical, neuropsychological, brain imaging electrophysiological and psychosocial functioning aspects of DSand PNS are reviewed. Expand
Antipsychotics and Amotivation
TLDR
The present results indicate that the negative impact of antipsychotics in this regard is overstated; conversely, the present results also indicate that the authors must look beyond antipsychotic treatment in patients with schizophrenia in their efforts to improve motivation. Expand
Cognitive Behavioral Therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study.
TLDR
CBT-n may be effective in reducing negative symptoms, and patients reported fewer dysfunctional beliefs about their cognitive abilities, performance, emotional experience, and social exclusion, and this reduction partially mediated the change in negative symptoms. Expand
Negative symptoms and social cognition: identifying targets for psychological interventions.
TLDR
The results highlight the relevance of self-concepts related to social abilities, dysfunctional beliefs, and global self-worth alone and in interaction with ToM deficits for negative symptoms and thereby provide a helpful basis for advancing psychosocial interventions. Expand
...
1
2
3
4
5
...